Proprietary AI analyst is now available
- Public Comps
- HBM Healthcare Investments
HBM Healthcare Investments Valuation Multiples
Discover HBM Healthcare Investments' revenue and EBITDA valuation multiples and investment history, alongside public comparables like Antin Infrastructure Partners, FIBRA Macquarie, GIMV, L1 Long Short Fund and more.
HBM Healthcare Investments Overview
About HBM Healthcare Investments
HBM Healthcare Investments Ltd is a Switzerland-based holding company. The firm actively invests in the human medicine, biotechnology, medical technology, and diagnostics sectors and related areas. The company holds and manages an international portfolio of companies.
Founded
2001
HQ

Employees
1
Website
Sectors
Financials (LTM)
EV
$2B
Valuation Multiples
Start free trialHBM Healthcare Investments Financials
HBM Healthcare Investments reported last 12-month revenue of $102M.
In the same LTM period, HBM Healthcare Investments generated $347M in net income.
Revenue (LTM)
HBM Healthcare Investments P&L
In the most recent fiscal year, HBM Healthcare Investments reported revenue of $347M and net income of $347M.
HBM Healthcare Investments is profitable as of last fiscal year, with net margin of 100%.
Financial data powered by Morningstar, Inc.
HBM Healthcare Investments Stock Performance
HBM Healthcare Investments has current market cap of $2B, and enterprise value of $2B.
Market Cap Evolution
HBM Healthcare Investments' stock price is $296.45.
HBM Healthcare Investments share price decreased by 2.7% in the last 30 days, and increased by 36.0% in the last year.
HBM Healthcare Investments has an EPS (earnings per share) of $52.53.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2B | $2B | 0.7% | -2.7% | 2.9% | 36.0% | $52.53 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialHBM Healthcare Investments Valuation Multiples
HBM Healthcare Investments trades at 20.4x EV/Revenue multiple.
EV / Revenue (LTM)
HBM Healthcare Investments Financial Valuation Multiples
As of June 5, 2026, HBM Healthcare Investments has market cap of $2B and EV of $2B.
HBM Healthcare Investments has a P/E ratio of 5.6x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified HBM Healthcare Investments Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


HBM Healthcare Investments Margins & Growth Rates
In the most recent fiscal year, HBM Healthcare Investments reported net margin of 100%.
HBM Healthcare Investments Margins
HBM Healthcare Investments Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
HBM Healthcare Investments Operational KPIs
HBM Healthcare Investments' revenue per employee in the last FY averaged $346.9M, while opex per employee averaged $3.3M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
HBM Healthcare Investments Competitors
HBM Healthcare Investments competitors include Antin Infrastructure Partners, FIBRA Macquarie, GIMV, L1 Long Short Fund, Tri-Continental, L1 Group, AFP ProVida, Patria Investments, Vukile Property Fund and Goodman New Zealand.
Most HBM Healthcare Investments public comparables operate across Asset Management.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 4.7x | 4.6x | 8.1x | 8.6x | |||
| 10.4x | 10.3x | 13.7x | 13.5x | |||
| 5.9x | - | - | - | |||
| 10.0x | - | - | - | |||
| 7.5x | - | - | - | |||
| 17.4x | 5.4x | 74.6x | 7.5x | |||
| 4.7x | - | 7.2x | - | |||
| 5.1x | 5.0x | 10.0x | 9.2x | |||
This data is available for Pro users. Sign up to see all HBM Healthcare Investments competitors and their valuation data. Start Free Trial | ||||||
Investments by HBM Healthcare Investments
HBM Healthcare Investments has invested in 79 companies to date.
Latest investment by HBM Healthcare Investments was on May 5th 2026. HBM Healthcare Investments invested in CellCentric in their $220M Series D round (EV/Revenue multiple available to Pro users).
Latest Investments by HBM Healthcare Investments
| Description | CellCentric is a Cambridge-headquartered clinical-stage biotechnology company developing p300/CBP inhibitors for cancer therapy. Its lead candidate, inobrodib, entered Phase II trials for multiple myeloma and NRAS-mutant melanoma in 2023. The oral drug targets bromodomain proteins in solid tumors like non-small cell lung cancer. Founded in 2016, CellCentric collaborates with the University of Cambridge on combination regimens with PD-1 inhibitors. | SnapNurse is a per diem staffing platform matching nurses and clinicians with hospitals using Instastaff AI algorithms. Tampa-headquartered since 2018, it handles credentialing, scheduling, and payments for shifts in Florida facilities. SnapNurse serves over 100 healthcare providers, supporting specialties like ICU and ER with mobile booking and timecard approvals. | Jixing Pharmaceuticals is a Shanghai-headquartered biotechnology firm developing therapeutics for cardiovascular and ophthalmic conditions. Its pipeline features JS201 for hypertrophic cardiomyopathy, JS102 for heart failure, JS301 for presbyopia and dry eye, and JS401 for hypertension, with multiple candidates in Phase 2 and 3 trials. Founded in 2019, the company has secured over $300 million in funding and collaborates with global pharma partners. | Electra Therapeutics is a biotechnology company developing SIRP-targeting antibodies to deplete pathological immune cells in hyperinflammatory diseases. Headquartered in New York City since 2020, its lead candidate ELA026 advances in Phase 2 trials for secondary hemophagocytic lymphohistiocytosis with orphan drug designation from FDA and EMA. ELA822 targets additional immunology indications, backed by $100 million in funding from investors including ARCH Venture Partners and Takeda. | |
| HQ Country | |||||
| HQ City | Cambridge | Atlanta, GA | Shanghai | San Francisco, CA | |
| Deal Date | 5 May 2026 | 28 Apr 2026 | 22 Jan 2026 | 22 Oct 2025 | |
| Round | Series D | Series A | Series D | Series C | |
| Raised | $220M | undisclosed | $287M | $183M | |
| Investors | Avego Bioscience Capital; BrightEdge (American Cancer Society VC unit); Fidelity; Forbion Capital Partners; HBM Healthcare Investments; Pfizer; RA Capital Management; Sofinnova Partners; Venrock Healthcare Capital Partners | Data Point Capital; HBM Healthcare Investments; Infinitum Asset Management; Suvretta Capital Management | Adage Capital Management; HBM Healthcare Investments; Hengdian Group; Invus; RA Capital Management; RTW Investments; SilverArc Capital; SR One; TCG Crossover | Blue Owl; Cormorant Asset Management; EQT; HBM Healthcare Investments; Mubadala Capital; New Leaf Venture Partners; Nextech Invest; OrbiMed; RA Capital Management; Redmile Group; Sanofi; Westlake Village BioPartners | |
| Valuation | $900M | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all HBM Healthcare Investments investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout HBM Healthcare Investments
| When was HBM Healthcare Investments founded? | HBM Healthcare Investments was founded in 2001. |
| Where is HBM Healthcare Investments headquartered? | HBM Healthcare Investments is headquartered in Switzerland. |
| How many employees does HBM Healthcare Investments have? | As of today, HBM Healthcare Investments has over 1 employees. |
| Is HBM Healthcare Investments publicly listed? | Yes, HBM Healthcare Investments is a public company listed on SIX Swiss Exchange. |
| What is the stock symbol of HBM Healthcare Investments? | HBM Healthcare Investments trades under HBMN ticker. |
| Who are competitors of HBM Healthcare Investments? | HBM Healthcare Investments main competitors include Antin Infrastructure Partners, FIBRA Macquarie, GIMV, L1 Long Short Fund, Tri-Continental, L1 Group, AFP ProVida, Patria Investments, Vukile Property Fund, Goodman New Zealand. |
| What is the current market cap of HBM Healthcare Investments? | HBM Healthcare Investments' current market cap is $2B. |
| What is the current revenue of HBM Healthcare Investments? | HBM Healthcare Investments' last 12 months revenue is $102M. |
| What is the current EV/Revenue multiple of HBM Healthcare Investments? | Current revenue multiple of HBM Healthcare Investments is 20.4x. |
| What is the current net income of HBM Healthcare Investments? | HBM Healthcare Investments' last 12 months net income is $347M. |
| How many companies HBM Healthcare Investments has acquired to date? | HBM Healthcare Investments hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies HBM Healthcare Investments has invested to date? | As of June 2026, HBM Healthcare Investments has invested in 79 companies. |
| What was the last HBM Healthcare Investments investment? | On 5th May 2026 HBM Healthcare Investments invested in CellCentric, participating in a $220M Series D round at $900M valuation, alongside Avego Bioscience Capital, BrightEdge (American Cancer Society VC unit), Fidelity, Forbion Capital Partners, Pfizer, RA Capital Management, Sofinnova Partners, and Venrock Healthcare Capital Partners. |
| In what companies HBM Healthcare Investments invested in? | HBM Healthcare Investments invested in Everest Medicines, Jixing Pharmaceuticals, Harmony Biosciences, Alumis, CellCentric, Odyssey Therapeutics, NiKang Therapeutics, Ambrx, Upstream Bio, Valo Health, Electra Therapeutics, Bluejay Therapeutics, Nuance Biotech, SK Biopharmaceuticals, Ignis Therapeutics, FogPharma, Karius, IO Biotech, VISEN Pharmaceuticals, Jianke, and 59 other companies. |
See public comps similar to HBM Healthcare Investments
Lists including HBM Healthcare Investments
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.


